Evidence map›Paper›PMID 36890535›Full record

Trial reportBMC health services research2023

Cost consequences of task-shifting intravitreal injections from physicians to nurses in a tertiary hospital in Norway.

Stine Bolme, Dordi Austeng, Tora Sund Morken, Turid Follestad, Vidar Halsteinli

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC health services research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02359149 (Intravitreal Injections by Nurses or Physicians), which is not on this map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02359149 nacompletednot on this map

Intravitreal Injections by Nurses or Physicians: a Randomized Controlled Trial Comparing Efficacy, Patient Satisfaction and Health Economy

TypeinterventionalSponsorSt. Olavs HospitalRan2015 to 2017Enrolled328ConditionsEye DiseasesArmsintravitreal injections given by a nurse, intravitreal injections given by a physician, Intravitreal injections, Anti-VEGF agents
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stine BolmeDepartment of Ophthalmology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. stine.bolme@ntnu.no.ORCID http://orcid.org/0000-0002-2540-9545
Dordi AustengDepartment of Ophthalmology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Tora Sund MorkenDepartment of Ophthalmology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Turid FollestadDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
Vidar HalsteinliRegional Centre for Health Care Improvement, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Norwegian University of Science and Technology · NOSt Olav's University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnti-vascular endothelial growth factor is a medicine administered intravitreally by an injection to maintain visual acuity in patients with a variety of retinal diseases. The demand for this treatment has grown considerably in the westernized world the last two decades and will continue to increase due to an aging population. Because of the high volume, injections seize enormous resources and represent high costs for both hospitals and society. Task-shifting of injections from physicians to nurses may be a means to reduce such costs, however the magnitude of possible savings has been poorly investigated. To this end we investigated changes in the hospital costs per injection, six-year cost projections of physician- versus nurse-administered injections for a Norwegian tertiary hospital and we compared the societal costs per patient per year.

methodsPatients (n = 318) were randomized to either physician- or nurse administered injections, and data were prospectively collected. Hospital costs per injection were calculated as the sum of training costs, personnel time and running expenses. The number of injections for the years 2014 - 21 from a Norwegian tertiary hospital was combined with age group specific injection prevalence and population projections to calculate cost projections for 2022 - 27. Societal costs per patient were calculated as the sum of hospital costs, transport costs for patients, caregivers' use of time, costs of ophthalmology consultations and community-based homecare.

resultsThe hospital costs per injection were 5.5 € higher for physicians compared to nurses (281.6 € versus 276.1 €). Cost projections estimated an annual hospital saving of task-shifting of 48 921 € for 2022 - 27. Societal costs per patient did not differ significantly between the two groups (mean 4988 € vs 5418 €, p = 0.398).

conclusionTask-shifting of injections from physicians to nurses can reduce hospital costs and increase the flexibility of physician resources. The annual savings are modest, but increased demand for injections might increase future cost savings. To achieve future savings for society, organizing ophthalmology consultations and injections on the same day to reduce the number of visits might be a solution.

trial registrationClinicalTrials.gov NCT02359149 (09/02/2015).

Indexed as

PhysiciansRetinal DiseasesAgedCost-Benefit AnalysisHumansIntravitreal InjectionsNorwayTertiary Care CentersAnti-VEGF injectionsCost projectionsHospital costsPhysicians versus nursesSocietal costsTask-shifting

Identifiers

PMID36890535
PMCPMC9996986
OpenAlexW4323542981

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.